Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide PAC1 antagonists

Peptide PAC1 antagonists

US Patent 11643440 · Granted May 9, 2023

Estimated economic value: $720,623,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating or ameliorating metabolic disorders using binding proteins fo2025
Bispecific antibody construct directed to MUC17 and CD32025
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agon2025
Apelin polypeptides2023
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof2023
Antibody constructs for CLDN18.2 and CD32023
Modified Fc molecules2022
Anti-human TREM2 antibodies and uses thereof2021
Apelin polypeptides2021
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agon2021
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof2020
Potent and selective inhibitors of Nav1.72019